The Use of Central Nervous System Active Drugs During Pregnancy

Author： Källén Bengt   Borg Natalia   Reis Margareta  

Publisher： MDPI

E-ISSN： 1424-8247|6|10|1221-1286

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.6, Iss.10, 2013-10, pp. : 1221-1286

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is Ghrelin Synthesized in the Central Nervous System?

By Cabral Agustina   López Soto Eduardo J.   Epelbaum Jacques   Perelló Mario  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 638-638

MDPI

Access to resources Recommend Favorite

Lactate as a Metabolite and a Regulator in the Central Nervous System

By Proia Patrizia   Di Liegro Carlo Maria   Schiera Gabriella   Fricano Anna   Di Liegro Italia  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1450-1450

MDPI

Access to resources Recommend Favorite

Liposomal Conjugates for Drug Delivery to the Central Nervous System

By Helm Frieder   Fricker Gert  

Pharmaceutics, Vol. 7, Iss. 2, 2015-04 ,pp. : 27-42

MDPI

Access to resources Recommend Favorite

Role of Cytokine Signaling during Nervous System Development

By Mousa Alyaa   Bakhiet Moiz  

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 13931-13957

MDPI

Access to resources Recommend Favorite

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System

By Zou Shenglong   Kumar Ujendra  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 833-833

MDPI

Access to resources Recommend Favorite